XML 90 R77.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity - Schedule of Stock Option Activity (Details) - USD ($)
10 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Successor [Member]    
Shares Underlying Options, March 15, 2018  
Shares Underlying Options, Granted 4,271,128  
Shares Underlying Options, Cancelled or terminated (612,707)  
Shares Underlying Options, Exercised  
Shares Underlying Options, December 31, 2018 3,658,421  
Shares Underlying Options, vested December 31, 2018  
Weighted Average Exercise Price Outstanding, March 15, 2018  
Weighted Average Exercise Price, Granted 11.10  
Weighted Average Exercise Price, Cancelled or terminated 11.08  
Weighted Average Exercise Price, Exercised  
Weighted Average Exercise Price December 31, 2018 11.10  
Weighted Average Exercise Price, vested December 31, 2018  
Weighted Average Remaining Contractual Life December 31, 2018 4 years 2 months 12 days  
Weighted Average Remaining Contractual Life, vested December 31, 2018 0 years  
Aggregate Intrinsic Value, Outstanding, December 31, 2018  
Aggregate Intrinsic Value, vested, December 31, 2018  
Predecessor [Member]    
Shares Underlying Options, March 15, 2018   75,561
Shares Underlying Options, Granted   283,333
Shares Underlying Options, Cancelled or terminated   (75,561)
Shares Underlying Options, Exercised  
Shares Underlying Options, December 31, 2018   283,333
Shares Underlying Options, vested December 31, 2018  
Weighted Average Exercise Price Outstanding, March 15, 2018   $ 98.69
Weighted Average Exercise Price, Granted   26.00
Weighted Average Exercise Price, Cancelled or terminated   98.69
Weighted Average Exercise Price, Exercised  
Weighted Average Exercise Price December 31, 2018 [1]   22.77
Weighted Average Exercise Price, vested December 31, 2018  
Weighted Average Remaining Contractual Life December 31, 2018   9 years 2 months 12 days
Weighted Average Remaining Contractual Life, vested December 31, 2018   0 years
Aggregate Intrinsic Value, Outstanding, December 31, 2018  
Aggregate Intrinsic Value, vested, December 31, 2018  
[1] In April 2017, options for the purchase of 216,667 common shares were modified such that the exercise price was reduced from $26.00 per share to $21.77 per share (see Note 14), reducing the weighted average exercise price from $26.00 per share to $22.77 per share.